Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052).
Hiroshi AsanoKatsutoshi OdaKosuke YoshiharaYuichiro AbeNoriomi MatsumuraMuneaki ShimadaHidemichi WatariTakayuki EnomotoPublished in: Journal of gynecologic oncology (2022)
Japan Primary Registries Network (JPRN) Identifier: jRCT2031210264.